Epigenetic deregulation of genomic imprinting in humans: causal mechanisms and clinical implications - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Epigenomics Année : 2013

Epigenetic deregulation of genomic imprinting in humans: causal mechanisms and clinical implications

Michael Girardot
  • Fonction : Auteur
Robert Feil

Résumé

Mammalian genes controlled by genomic imprinting play important roles in development and diverse postnatal processes. A growing number of congenital disorders have been linked to genomic imprinting. Each of these is caused by perturbed gene expression at one principal imprinted domain. Some imprinting disorders, including the Prader-Willi and Angelman syndromes, are caused almost exclusively by genetic mutations. In several others, including the Beckwith-Wiedemann and Silver-Russell growth syndromes, and transient neonatal diabetes mellitus, imprinted expression is perturbed mostly by epigenetic alterations at 'imprinting control regions' and at other specific regulatory sequences. In a minority of these patients, DNA methylation is altered at multiple imprinted loci, suggesting that common trans-acting factors are affected. Here, we review the epimutations involved in congenital imprinting disorders and the associated clinical features. Trans-acting factors known to be causally involved are discussed and other trans-acting factors that are potentially implicated are also presented.
Fichier principal
Vignette du fichier
Girardot et al_Epigenomics_2013.pdf (1.5 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03027056 , version 1 (26-11-2020)

Identifiants

Citer

Michael Girardot, Robert Feil, David Llères. Epigenetic deregulation of genomic imprinting in humans: causal mechanisms and clinical implications. Epigenomics, 2013, 5 (6), pp.715 - 728. ⟨10.2217/epi.13.66⟩. ⟨hal-03027056⟩
78 Consultations
89 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More